What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Cardiology
His scientific interests lie mostly in Internal medicine, Heart failure, Cardiology, Ejection fraction and Heart disease.
His Internal medicine research integrates issues from Placebo and Endocrinology.
Dirk J. van Veldhuisen has included themes like Randomized controlled trial, Surgery, Anemia, Intensive care medicine and Hazard ratio in his Heart failure study.
The concepts of his Ejection fraction study are interwoven with issues in Carvedilol, Beta blocker, Clinical endpoint and Breast cancer.
Dirk J. van Veldhuisen interconnects Pregnancy, Sudden death and Randomization in the investigation of issues within Heart disease.
His research integrates issues of Eplerenone, Spironolactone, Brain natriuretic peptide and Coronary artery disease in his study of Myocardial infarction.
His most cited work include:
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms (1857 citations)
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 (1542 citations)
- Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population (1290 citations)
What are the main themes of his work throughout his whole career to date?
Dirk J. van Veldhuisen mostly deals with Internal medicine, Heart failure, Cardiology, Ejection fraction and Myocardial infarction.
His Internal medicine study which covers Endocrinology that intersects with Gastroenterology.
His Heart failure research includes themes of Randomized controlled trial, Surgery, Intensive care medicine and Hazard ratio.
His Cardiology study combines topics from a wide range of disciplines, such as Placebo and Heart rate.
His biological study spans a wide range of topics, including Eplerenone, Clinical endpoint, Blood pressure and Cohort.
The various areas that he examines in his Renal function study include Creatinine and Kidney.
He most often published in these fields:
- Internal medicine (82.43%)
- Heart failure (72.91%)
- Cardiology (63.18%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (82.43%)
- Heart failure (72.91%)
- Cardiology (63.18%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Heart failure, Cardiology, Ejection fraction and Atrial fibrillation.
Borrowing concepts from In patient, Dirk J. van Veldhuisen weaves in ideas under Internal medicine.
His Heart failure research is multidisciplinary, relying on both Gastroenterology, Hazard ratio, Confidence interval and Renal function.
He studied Cardiology and Stroke that intersect with Rivaroxaban.
His work is dedicated to discovering how Ejection fraction, Beta blocker are connected with ACE inhibitor and other disciplines.
Dirk J. van Veldhuisen works mostly in the field of Atrial fibrillation, limiting it down to topics relating to Risk factor and, in certain cases, Quality of life, as a part of the same area of interest.
Between 2017 and 2021, his most popular works were:
- Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. (203 citations)
- Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. (174 citations)
- Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease (146 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Heart failure
- Cardiology
Dirk J. van Veldhuisen mainly investigates Internal medicine, Heart failure, Cardiology, Ejection fraction and Hazard ratio.
His Internal medicine study frequently draws connections between adjacent fields such as Gastroenterology.
His research in Heart failure intersects with topics in Confidence interval, Proportional hazards model, ACE inhibitor, Biomarker and Cohort.
His Cardiology research incorporates themes from Clinical trial and Angiotensin receptor.
His Ejection fraction research includes elements of Cohort study, Diabetes mellitus, Magnetic resonance imaging, Fibrosis and Hyperkalemia.
His work carried out in the field of Hazard ratio brings together such families of science as Renal function, Urology, Loop diuretic, Diuretic and Volume overload.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
